← Back to Search

Pharmacist Led Intervention for Frailty

N/A
Waitlist Available
Research Sponsored by Emily
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
DBI score >0 (taking ≥1 regular medication with a sedative or anticholinergic effect prior to admission)
Age ≥70 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This trial is testing whether using the DBI Calculator© tool can help hospital pharmacists manage medicines better for older adults in Canada, specifically looking at reducing the number of harmful drugs patients are taking and improving health outcomes.

Who is the study for?
This trial is for English-speaking patients aged 70 or older who are hospitalized in Nova Scotia and have a Drug Burden Index (DBI) score above zero, indicating they're taking at least one medication with sedative or anticholinergic effects. It's not for those expected to be discharged within a day of joining, admitted less than two days, in the terminal phase of illness, or living outside Nova Scotia.Check my eligibility
What is being tested?
The study tests if using the DBI Calculator© by hospital pharmacists can optimize medication use and improve health outcomes in older adults. The tool helps identify potentially harmful medications and combinations, aiming to reduce drug-related issues and enhance quality of life.See study design
What are the potential side effects?
Since this intervention involves adjusting current medications rather than adding new ones, side effects would relate to changes in drug regimens. This could include withdrawal symptoms from reduced sedatives or anticholinergics, but specific side effects will vary based on individual medication adjustments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently taking medication that can make me drowsy or dry my mouth.
Select...
I am 70 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with changed or unchanged DBI score at discharge compared to admission
Secondary outcome measures
Clinical outcomes after hospitalization
Clinical outcomes during hospitalization
Number of participants with changed (or unchanged) DBI score
+2 more

Trial Design

2Treatment groups
Active Control
Group I: Retrospective Chart ReviewActive Control1 Intervention
Specifically, it consists of: A retrospective study (NB: ethics for this part of the overall study has been sought separately and already approved, file number 1023666). A before/after intervention A multiple case study (a sub-study of the before/after intervention)
Group II: InterventionActive Control1 Intervention
A before/after intervention A multiple case study (a sub-study of the before/after intervention)

Find a Location

Who is running the clinical trial?

EmilyLead Sponsor
Canadian Frailty NetworkOTHER
20 Previous Clinical Trials
20,701 Total Patients Enrolled

Media Library

Pharmacist Led Intervention utilizing the DBI Calculator© Clinical Trial Eligibility Overview. Trial Name: NCT03698487 — N/A
Anticholinergic Syndrome Research Study Groups: Retrospective Chart Review, Intervention
Anticholinergic Syndrome Clinical Trial 2023: Pharmacist Led Intervention utilizing the DBI Calculator© Highlights & Side Effects. Trial Name: NCT03698487 — N/A
Pharmacist Led Intervention utilizing the DBI Calculator© 2023 Treatment Timeline for Medical Study. Trial Name: NCT03698487 — N/A

Frequently Asked Questions

~12 spots leftby Aug 2024